Searched for
MOREPEN LABORATORIES RESULTS
Mid and smallcap stocks rebound sharply; was a bear attack just a 1-day show?Mazagon Dock Shipbuilders, JSW Energy, NHPC, Coromandel International, Oil India, Indian Railway Finance Corporation, and Sona BLW Precisio...- Market Movers: Investors dump Nykaa shares ahead of earningsNykaa has faced massive selloff off late as Street dumped shares of richly valued new-age companies against the backdrop of Fed rate hikes,...
- Morepen Laboratories Q3 Results: Profit dips 10% to Rs 22 crNet revenue, however, rose to Rs 399.19 crore in the third quarter as compared with Rs 310.26 crore in the same period of 2020-21, Morepen ...
- Russian fund seeks Sputnik M registration for adolescentsIn April 2021, India had granted an emergency use authorisation for Sputnik V. RDIF said its Sputnik V has been authorised in 71 countries ...
- Morepen Labs Q2 results: Net profit up 38% at Rs 37 crore"With massive increase in active pharmaceutical ingredient (API) demand globally and more particularly with frequent supply disruptions fro...
- Morepen Laboratories Q1 results: Net profit jumps 57% to Rs 30 crIts net revenue stood at Rs 388.31 crore in the quarter under consideration, up 50 per cent against Rs 258.97 crore a year ago, Morepen Lab...
- Stocks in news: Reliance Inds, Hindustan Unilever, Titan, Bajaj Auto and Ambuja CementsHindustan Unilever, Titan and Bajaj Auto, Ambuja Cements, Motherson Sumi, Bajaj Holdings, Shriram Transport, AU SFB, IndiaMart InterMesh an...
- Stocks in the news: ICICI Bank, SBI Card, TechM, HDFC Life, HCL Tech and Morepen LabsHCL Technologies is engaging closely with clients to prioritise work, and shifting some workload from India to other geographies.
- Morepen Labs Q3 results: Net profit rises over two-fold to Rs 24 crConsolidated total revenue of the company stood at Rs 310.26 crore for the quarter under consideration. It was Rs 234.65 crore for the same...
- Morepen Labs Q1 results: Net profit jumps over two-fold to Rs 19.36 croreThe company had posted a net profit of Rs 7.65 crore in the corresponding period of previous fiscal, Morepen Laboratories said in a filing ...
- Germ theory: How probiotic products are flying off the shelvesProbiotics gain demand in the new millennium but there is still a lot of grey area around the science of ingesting good bacteria.
- VIP, Adani Green Energy, Kwality and ONGC among top stocks to track todayHere's a look at the top stocks that are likely to hog limelight in today's trading session.
- Taro Q4 results spook pharma majors, shares tankSun pharma and Divi’s Labs settled lower by 3.17 per cent and 3.29 per cent, respectively.
- Fifteen stocks in focus on Friday, 23 September 2016The Indian market is expected to open flat. Here is a list of top fifteen stocks that are likely to be in focus today.
- Morepen to sell anti-asthmatic drug Montelukast in Europe, North AmericaPharma firm Morepen Laboratories today said it is preparing to sell anti-asthmatic drug Montelukast in European and North American markets.
- Pharma cos oppose DCGI's ban on emergency contraceptive pill adsCos say the move contradicts government's health policies besides hurting their investments.
- Morepen lines up debt recastMorepen Laboratories, the loss-making, debt-laden pharma company, has struck a deal with lenders to restructure its debt and is also prepar...
- Avenue Capital to pick 15% in Morepen for Rs 80 croreUS-based Avenue Capital, a hedge fund that focuses on distressed and undervalued debt and equity opportunities, is in an advanced stage of ...
- Morepen Lab partly settles debt from banksPharmaceutical company Morepen Laboratories on Tuesday said it has issued fresh capital of Rs 103 crore to banks and financial institutions...
- Morepen to part-pay debt as StanChart PE buys stakeThe debt-ridden Morepen Laboratories has got a fresh lease of life.
Load More
